Walleye Capital’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$263K Buy
+2,600
New +$269K ﹤0.01% 3279
2025
Q2
Sell
-600
Closed -$60.8K 4620
2025
Q1
$60.8K Hold
600
﹤0.01% 3789
2024
Q4
$55.4K Sell
600
-4,800
-89% -$471K ﹤0.01% 4339
2024
Q3
$522K Buy
+5,400
New +$485K ﹤0.01% 3262
2023
Q4
Sell
-2,400
Closed -$161K 5083
2023
Q3
$161K Buy
+2,400
New +$165K ﹤0.01% 3698
2020
Q1
Sell
-24,386
Closed -$1.34M 1129
2019
Q4
$1.34M Buy
+24,386
New +$1.32M 0.09% 314

Other funds holding EHC

Walleye Capital's EHC Position: Q2 2026 in Review

Walleye Capital opened a new position in Encompass Health (EHC) in Q2 2026: 224 shares worth $22.6K. The stake represents ﹤0.01% of the portfolio and ranks #4363 among its holdings. This is a return to the name: Walleye Capital previously reported a position in EHC as recently as Q3 2025.

Walleye Capital first reported a position in EHC in Q4 2019 and has held it in 12 quarters since. The position peaked at $800K in Q2 2025. 598 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Walleye Capital held 224 shares of Encompass Health worth $22.6K as of Q2 2026.
  • Encompass Health was a new Walleye Capital position in Q2 2026.
  • Encompass Health made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4363 holding.
  • Walleye Capital first reported a position in Encompass Health in Q4 2019 and has held it in 12 quarters since.
  • Walleye Capital's Encompass Health position peaked at $800K in Q2 2025.
  • 598 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.